newsfilter
← Latest News
PR Newswire·

Rigel to Participate in Upcoming September Investor Conferences

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), a commercial stage biotechnology company focused on hematologic disorders and cancer, today announced...